Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Disaggregation of Revenue (Details)

v3.21.2
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue $ 121,724 $ 86,977 $ 237,257 $ 193,007
Clinical Services        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 101,405 73,884 197,892 166,866
Clinical Services | Client direct billing        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 63,137 45,244 123,846 99,535
Clinical Services | Commercial Insurance        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 20,528 15,148 39,102 37,142
Clinical Services | Medicare and Medicaid        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 17,484 13,541 34,634 30,024
Clinical Services | Self-Pay        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue 256 (49) 310 165
Pharma Services        
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]        
Total revenue $ 20,319 $ 13,093 $ 39,365 $ 26,141